Transparency in Covid-19 pandemic vaccination is vital
Friday March 05 2021
Summary
We applaud the government upon this achievement and appreciate the Ministry of Health for staying the course and for sharing an elaborate plan of how the vaccines will be distributed, with whom, when and how, among other concerns.
Advertisement
On March 2, the Minister of Health shared a statement with the media and the public announcing a number of activities around the mass immunisation of Ugandans and foreigners aged 18 years and above against the deadly Covid-19.
We applaud the government upon this achievement and appreciate the Ministry of Health for staying the course and for sharing an elaborate plan of how the vaccines will be distributed, with whom, when and how, among other concerns.
Daily Monitor
Wednesday February 17 2021
A vial containing the Covid-19 vaccine by AstraZeneca at the Robert Bosch Hospital in Stuttgart, Germany. PHOTO AFP
Advertisement
The AstraZeneca vaccine being purchased by government has 63 per cent efficacy in preventing Covid-19 illness, the World Health Organisation (WHO) revealed on Monday.
“The AstraZeneca/Oxford product is a viral vectored vaccine. AstraZeneca has been found to have 63.09 per cent efficacy and is suitable for low and middle-income countries due to easy storage requirements,” WHO said in a statement, adding the vaccine has been listed for emergency use.
This efficacy is, however, 30 per cent below the Pfizer and Moderna vaccines, which are being used in other countries, including Rwanda.
comments
This article originally appeared at Common Dreams. It is licensed under a Creative Commons Attribution-Share Alike 3.0 License. Feel free to republish and share widely.
Advocates of a people s vaccine responded critically to an announcement Thursday from AstraZeneca that the British-Swedish pharmaceutical giant saw its profits double last year, even while supplying its coronavirus vaccine at no profit which it has pledged to do for the duration of the pandemic, as defined by the company. The performance last year marked a significant step forward for AstraZeneca. Despite the significant impact from the pandemic, we delivered double-digit revenue growth to leverage improved profitability and cash generation, CEO Pascal Soriot said in a statement about the company s 2020 results. The consistent achievements in the pipeline, the accelerating performance of our business, and the progress of the Covid-19 vaccine demonstrated what we can achieve.
Imported Chinese COVID vaccine restricted to Chinese nationals
December 10, 2020 Written by URN
The imported 4,000 doses of the Chinese experimental COVID-19 vaccine will be restricted to only Chinese nationals, Uganda s Health ministry has revealed.
The ministry came out on the matter on Tuesday after a letter by the Health minister, Dr. Ruth Jane Aceng authorizing the importation of 4,000 doses of the vaccine also known as Verocell leaked to the public.
With impending questions about the safety of the vaccine that was rolled out in October for emergency use in China and is yet to receive approval from the World Health Organization (WHO) for international use, Dr. Alfred Driwale, the head of Uganda Nat